A097
TORS WITH NECK DISSECTION VERSUS PRIMARY NON-SURGICAL TREATMENT IN STAGE I AND II HPV-NEGATIVE OROPHARYNGEAL CANCER
Oropharynx / HPV Related Disease
Brian Morris, MD1; Craig A Bollig, MD2
1Penn State College of Medicine; 2Rutgers Robert Wood Johnson Medical School
A098
DETERMINANTS OF PATIENT-REPORTED TASTE PROBLEMS IN OROPHARYNGEAL CANCER SURVIVORS
Christopher W Ogboe, OD1; Puja Aggarwal, PhD, BDS, MPH1; Adam S Garden, MD2; Frank E Mott, MD, FACP3; Ryan P Goepfert, MD4; Ruth A Aponte Wesson, DDS, MS, FACP, FAAMP4; Ann M Gillenwater, MD4; Mayur Patel, BSA, MS, IV5; Clifton D Fuller, MD, PhD2; Stephen Y Lai, MD, PhD4; G. Brandon Gunn, MD2; Mark S Chambers, DMD, MS4; Erich M Sturgis, MD, MPH5; Ehab Y Hanna, MD4; Katherine A Hutcheson, PhD4; Sanjay Shete, PhD1
1Department of Epidemiology, The University of Texas M.D Anderson Cancer Center; 2Department of Radiation Oncology, The University of Texas M.D Anderson Cancer Center; 3Department of Thoracic Head and Neck Medical Oncology, The University of Texas M.D Anderson Cancer Center; 4Department of Head and Neck Surgery, The University of Texas M.D Anderson Cancer Center; 5The University of Texas Health Science Center at Houston; McGovern Medical School
A099
DIFFERENCES IN SURVIVAL OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA BY SUBSITE AND HPV STATUS
Shreya Chidarala, BS; Michael C Shih, BS; Michael Bobian, MD; Lindsey Shehee, MD; Alana Aylward, MD; John Kaczmar, MD; Anand K Sharma, MD; Shaun A Nguyen, MD; Terry A Day, MD
Medical University of South Carolina
A100
HPV IN THE CERVIX AND OROPHARYNX: ASSESSING THE PREVALENCE OF GYNECOLOGIC CANCER AND PRECANCEROUS LESIONS IN WOMEN WITH OROPHARYNEAL CANCER
Austin C Cao, BA; Erin R Cohen, MD; Robert M Brody, MD
University of Pennsylvania Department of Otorhinolaryngology- Head and Neck Surgery
A101
EVALUATING PREDICTORS OF FINANCIAL TOXICITY IN HEAD AND NECK CANCER PATIENTS TREATED WITH TRANSORAL ROBOTIC SURGERY
Austin C Cao, BA; Evan Cretney, MD; Leila J Mady, MD, PhD, MPH; Jason G Newman, MD; Ara C Chalian, MD; Karthik Rajasekaran, MD; Steven B Cannady, MD; Devraj Basu, MD, PhD; Gregory S Weinstein, MD; Robert M Brody, MD
A102
TREATMENT TRENDS AMONG HEAD AND NECK SQUAMOUS CELL CARCINOMA IN THE UNITED STATES
Melina J Windon, MD1; Eleni M Rettig, MD2; Carole Fakhry, Professor1
1Johns Hopkins University SOM; 2Brigham and Women's Hospital
A103
VALIDATION OF AJCC-8 FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA IN APPALACHIANS WITH MULTIPLE CONFOUNDERS
Clayton Burruss, BS1; Christine Sharrer, MS1; J. Zachary Porterfield, MD, PhD2; Alexandra E Kejner, MD2
1University of Kentucky College of Medicine; 2University of Kentucky Department of Otolaryngology - Head and Neck Surgery
A104
SURGERY FOR THE TREATMENT OF HPV-NEGATIVE SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX - A SYSTEMATIC REVIEW AND META-ANALYSIS.
Erica H McArdle, MD1; Mustafa G Bulbul, MD, MPH1; Chantz Collins, BS2; Umamaheswar Duvvuri, MD, PhD3; Neil Gross, MD, FACS4; Meghan T Turner, MD1
1Department of Otolaryngology-Head and Neck Surgery, West Virginia University School of Medicine; 2West Virginia University; 3Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh; 4Department of Otolaryngology-Head and Neck Surgery, University of Texas, MD Anderson Cancer Center
A105
INTERDISCIPLINARY WORKSHOP THAT IMPROVES HPV-MEDIATED OROPHARYNGEAL CANCER KNOWLEDGE AMONG PRIMARY CARE RESIDENTS
Shaghauyegh S Azar, BS1; Lauran K Evans, MD, MPH2; Brooke M Su-Velez, MD, MPH3; Maie A St. John, MD, PhD2
1David Geffen School of Medicine at UCLA; 2Department of Head and Neck Surgery, University of California Los Angeles; 3Department of Otolaryngology - Head and Neck Surgery, Stanford University
A106
IMPROVING MARGIN ASSESSMENT DURING TRANSORAL ROBOTIC SURGERY FOR P16+ OROPHARYNGEAL SQUAMOUS CELL CARCINOMA WITH UTILIZATION OF INTRAOPERATIVE POSITIVE CONTROLS
Alice C Yu, BA1; Jeffrey D Goldstein, MD2; Elliot Abemayor, MD, PhD1; Abie H Mendelsohn, MD1
1Department of Head and Neck Surgery, University of California Los Angeles; 2Department of Pathology, University of California Los Angeles
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX